Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Prepaid Assets (2021 - 2025)

Krystal Biotech's Prepaid Assets history spans 5 years, with the latest figure at $14.0 million for Q4 2025.

  • For Q4 2025, Prepaid Assets rose 20.15% year-over-year to $14.0 million; the TTM value through Dec 2025 reached $14.0 million, up 20.15%, while the annual FY2025 figure was $14.0 million, 20.15% up from the prior year.
  • Prepaid Assets for Q4 2025 was $14.0 million at Krystal Biotech, up from $10.1 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $16.9 million in Q2 2025 and bottomed at $2.2 million in Q2 2021.
  • The 5-year median for Prepaid Assets is $6.0 million (2023), against an average of $7.1 million.
  • The largest annual shift saw Prepaid Assets grew 10.48% in 2022 before it surged 158.29% in 2025.
  • A 5-year view of Prepaid Assets shows it stood at $4.2 million in 2021, then grew by 10.48% to $4.6 million in 2022, then skyrocketed by 45.53% to $6.7 million in 2023, then skyrocketed by 73.83% to $11.7 million in 2024, then rose by 20.15% to $14.0 million in 2025.
  • Per Business Quant, the three most recent readings for KRYS's Prepaid Assets are $14.0 million (Q4 2025), $10.1 million (Q3 2025), and $16.9 million (Q2 2025).